Sung-Nam Lim

1PUBLICATIONS
7CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Mar 12, 2025
Efficacy of combined CD38 and PD-1 inhibition with isatuximab and cemiplimab for relapsed/refractory NK/T-cell lymphoma.

Seok Jin Kim, Jing Quan Lim, Sang Eun Yoon

Pageof 1

Frequent Collaborators

1 joint publications

Seok Jin Kim

1 joint publications

Jing Quan Lim

1 joint publications

Sang Eun Yoon

1 joint publications

Sung Yong Oh